CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PC2GJ26

Market Closed - Boerse Frankfurt Warrants 15:40:18 2024-05-24 EDT
51.76 EUR +2.01% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+4.86%
1 month+6.13%
Date Price Change
24-05-24 51.75 +1.99%
24-05-23 50.74 -1.03%
24-05-22 51.27 -1.48%
24-05-21 52.04 -1.33%
24-05-20 52.74 +0.50%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 03:40 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC2GJ2
ISINDE000PC2GJ26
Date issued 2023-12-19
Strike 60
Maturity 2025-03-21 (301 Days)
Parity 1 : 1
Emission price 40.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 53.41
Lowest since issue 40.64
Spread 0.22
Spread %0.42%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus